Why the study?
Individuals with a restrictive spirometric pattern have a high burden of cardiovascular and metabolic morbidity, but the prevalence of elevated cardiac biomarkers and their association with mortality were unclear.
Does elevated cardiac troponin predict mortality in individuals with a restrictive spirometric pattern compared to normal lung function?
Does elevated cardiac troponin predict mortality in individuals with a restrictive spirometric pattern compared to normal lung function?
Elevated cardiac troponin is common in individuals with a restrictive spirometric pattern and serves as a strong independent predictor of mortality in this population.
Troponin may flag higher mortality risk in restrictive spirometry; leaves open whether measurement improves risk stratification or outcomes.
Background: Individuals with a restrictive spirometric pattern have a high burden of cardiovascular and metabolic morbidity. Objective: To assess prevalence of elevated cardiac biomarkers among individuals with a restrictive spirometric pattern compared to those with a normal lung function and to evaluate the association between cardiac biomarkers and mortality. Methods: In 2002-04, individuals with airway obstruction were identified from population-based cohorts, together with age- and sex-matched non-obstructive referents. The analysis population consisted of the non-obstructive referents stratified according to whether they had a restrictive spirometric pattern or normal lung function in whom cardiac biomarkers were measured. Deaths were recorded until 31 December 2010. Results: Participants with a restrictive spirometric pattern were older and more likely to be obese with a higher burden of cardiovascular risk factors than those with normal function. Elevated cardiac troponin but not natriuretic peptide levels were more common in those with a restrictive spirometric pattern independent of age, sex, BMI, or risk factors (adjusted OR 1.8, 95% CI 1.29-2.74). At 5 years, death occurred more frequently in participants with restrictive spirometric pattern compared to those with normal function (15.7% [31/197] versus 7.6% [57/751]), with highest mortality rate in those with restriction and elevated cardiac troponin (28.7% [27/94]). Cardiac troponin was independently associated with death among those with a restrictive spirometric pattern (HR 4.91, 95% CI 1.58-15.26) but not in those with normal lung function. Conclusion: Cardiac troponin was elevated more often in people with a restrictive spirometric pattern in whom it was a strong independent predictor of death.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: